Psoriatic arthritis
Arthritis often goes undetected in people with psoriasis
Up to 15% of people with psoriasis have undiagnosed arthritis that’s related to the skin condition, according to a new review published in the Journal of the American Academy of Dermatology. And that’s despite the fact that skin psoriasis comes before the onset of psoriatic arthritis in 84% of people with psoriasis. Continue reading
Non-steroidal anti-inflammatory drugs (NSAIDs) may inhibit ovulation after just 10 days
Short-term use of over-the-counter drugs could negatively impact fertility, according to a small study presented at the European League Against Rheumatism Annual Congress.
A total of 39 nine women of childbearing age who have back pain took part in the study, and received diclofenac (100mg once daily), naproxen (500mg twice daily) and etoricoxib (90mg once daily) or placebo. Continue reading
Psoriatic arthritis drug recommended for use in the UK – decision reversal
A psoriatic arthritis therapy has been recommended for use in the UK by the National Institute for Health and Care Excellence (NICE), a reversal of its previous decision, and great news for people with psoriatic arthritis, giving them access to a greater choice of effective drugs. Continue reading
Coping with motherhood, psoriatic arthritis and osteoarthritis in her early forties has been an uphill struggle, but Kate Thouless is determined to make the most of family life
I first started having pains in my knees following the birth of my eldest daughter in 2008. I went to the doctor about a year later who referred me to a physiotherapist as I was unable to sleep most nights due to the pain. For a while I was symptom-free but during my second pregnancy (in 2011) I experienced pelvic pain and the knee pain seemed to return with a vengeance about 18 months later. Continue reading
Anti-TNF therapies reduce disease activity in most people with psoriatic arthritis – fresh evidence
New evidence has come to light about the substantial benefits that anti-TNF therapies (a class of biologic drugs) can deliver to people with psoriatic arthritis.
Canadian experts aimed to identify disease characteristics, outcomes and predictors of minimal disease activity (MDA) in 226 people with psoriatic arthritis who were treated with TNF-alpha blockers. Continue reading
